Three companies have led the pack in microbiome startup investments over the past five years. This is who they are and what they invest in.
![Artist's impression of gut microflora](https://globalventuring.com//content/uploads/2024/03/gut-microbiome.png)
Johnson & Johnson, the US-based pharmaceuticals company, has been one of the most active investors in microbiome-based startups over the past five years, followed by Royal DSM, the Dutch nutrition, health and beauty company.
Johnson & Johnson’s, for example, was an early backer of DayTwo, an Israeli startup that uses sequencing of the gut biome to create personalised nutritional advice to help people…
![](https://globalventuring.com//content/themes/mawsonia/sig/logo.png)
Maija Palmer
Maija Palmer is editor of Global Venturing and puts together the weekly email newsletter (sign up here for free).